glp-1 providers π¨ Important Update for SHBP Members π¨ State Health Benefit Plan has new prescribing rules starting February 1, 2026. βοΈ You may continue filling GLP-1 medications for weight loss with your Physicians Say GLP-1s for Weight
Description
[15] Hence, the title of the study we've been discussing, "Berberine is associated with protection of colon enterocytes from mitochondrial overheating"

Tirzepatide is a once-weekly GIP receptor and GLP-1 receptor agonist that combines the actions of both incretins into a single novel molecule

The side effects havent been studied enough to know if the medication is transferred into breastmilk and then to an infant

Nausea, vomiting, diarrhea, and constipation were the most common gastrointestinal adverse effects

The companies listed in this report are a curated selection - not the full competitive universe

Jody Dushay, an endocrinologist at Beth Israel Deaconess Medical Center and assistant professor at Harvard Medical School
